The combination of MnLNPs@mRNAE7 vaccine with anti-PD-L1 antibody (αPD-L1) has reprogrammed the immunosuppressive tumor microenvironment, further augmenting the antitumor effect [143]. This evidence concerns the gene CD274 and neoplasm.